My site

 Newly released technology tests 11 key criteria that leading proxy advisor uses to assess plans

AMSTERDAM & LONDON & SAN FRANCISCO-Friday 20 September 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- CGLytics, a leading global provider of governance data and analytics, and Glass Lewis, the world’s leading independent provider of governance and engagement support services, today announced the launch of Glass Lewis’ Equity Compensation Model (ECM) - a powerful new application for assessing U.S. equity-based compensation plans, available exclusively via CGLytics.

This new application provides invaluable intelligence with year-round, on-demand access to Glass Lewis’ methodology which is used to evaluate the overall favorability of current and future equity plans, including tests against 11 key criteria. Companies and investors can now instantly test, review and adjust the same individual inputs as Glass Lewis’ analysts to ensure the bes ... Read more »

Expansion will help financial institutions quickly and securely process global corporate cross-border payments

SAN FRANCISCO-Saturday 21 September 2019 [ AETOS Wire ]

(BUSINESS WIRE) -- Visa Inc. (NYSE:V) today announced that its Visa B2B Connect network has doubled its reach – from 30 global trade corridors at launch in June 2019, to 62, with the goal to expand to over 100 countries in 2020.

In addition, Infosys, a global leader in next-generation digital services and consulting, is integrating with the Visa B2B Connect network to bring Visa B2B Connect platform access to their participating financial institutions worldwide.

Through this new connection, participating financial institutions worldwide can take advantage of the ability to quickly and securely process corporate cross-border payments globally through Visa B2B Connect.1

“Visa B2B Connect is a fast, secure and more efficient network, designed specifically ... Read more »

 Boehringer Ingelheim strengthens its retinal disease pipeline portfolio with new co-development and license agreement

The partners aim to develop novel therapies with significantly reduced patient burden for eye diseases with limited or only insufficient treatment options using Inflammasome Therapeutics’ intravitreal drug delivery technology

Inflammasome Therapeutics is entitled to receive up to $160 million in milestone and gated development payments as well as tiered royalties and other milestones due on commercialization

INGELHEIM, Germany and NEWTON, Mass.-Friday 20 September 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases. By combining Inflammasome’s unique intravitreal (IVT) drug delivery technologies with Boe ... Read more »

Company recognized for global growth and innovation, corporate social responsibility and delivering excellence in customer service

LAS VEGAS.-Saturday 21 September 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced it has been named a Gold Stevie® Award winner for Company of the Year – Computer Services in both the 2019 American Business Awards® (ABA) and the 2019 International Business Awards® (IBA). Rimini Street was also recognized with two additional Gold Stevie ABAs for Customer Service Team of the Year and Product Management Team of the Year.

Global Growth and Service Innovation

Rimini Street garnered the Gold Stevie award for Company of the Year – Computer Services in both the American and International ... Read more »

 Stakeholders meet at Patient Safety Movement Foundation Midyear Planning meeting to plan for ZERO preventable deaths in hospitals

IRVINE, Calif. -Friday 20 September 2019 [ AETOS Wire ]

(BUSINESS WIRE)-- On the same day the World Health Organization (WHO) designated World Patient Safety Day, The Patient Safety Movement Foundation’s (PSMF) Midyear Planning Meeting (MYPM) brought together more than a hundred patient safety stakeholders from across seven countries for intimate discussions about how to achieve ZERO preventable deaths in hospitals. More than 200,000 people die due to medical errors in the US each year, and more the 4.8 million worldwide.

During this important meeting, administrators, clinicians, patient safety advocates, family members and other patient safety leaders from across the healthcare ecosystem had an opportunity to share experiences and expertise to help develop solutions to eliminate preventable patient death ... Read more »